These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


115 related items for PubMed ID: 9132139

  • 1. Tenascin-C expression correlates with macrophage invasion in Duchenne muscular dystrophy and in myositis.
    Gullberg D, Velling T, Sjöberg G, Salmivirta K, Gaggero B, Tiger CF, Edström L, Sejersen T.
    Neuromuscul Disord; 1997 Jan; 7(1):39-54. PubMed ID: 9132139
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tenascin-C expression in dystrophin-related muscular dystrophy.
    Settles DL, Cihak RA, Erickson HP.
    Muscle Nerve; 1996 Feb; 19(2):147-54. PubMed ID: 8559162
    [Abstract] [Full Text] [Related]

  • 5. Dystrophin in skeletal muscle. II. Immunoreactivity in patients with Xp21 muscular dystrophy.
    Nicholson LV, Davison K, Johnson MA, Slater CR, Young C, Bhattacharya S, Gardner-Medwin D, Harris JB.
    J Neurol Sci; 1989 Dec; 94(1-3):137-46. PubMed ID: 2693618
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Increased expression of HLA ABC class I antigens by muscle fibres in Duchenne muscular dystrophy, inflammatory myopathy, and other neuromuscular disorders.
    Appleyard ST, Dunn MJ, Dubowitz V, Rose ML.
    Lancet; 1985 Feb 16; 1(8425):361-3. PubMed ID: 2857418
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dystrophin and nebulin in the muscular dystrophies.
    Patel K, Voit T, Dunn MJ, Strong PN, Dubowitz V.
    J Neurol Sci; 1988 Nov 16; 87(2-3):315-26. PubMed ID: 3062133
    [Abstract] [Full Text] [Related]

  • 11. Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD-carriers and control subjects.
    Mizuno Y, Nonaka I, Hirai S, Ozawa E.
    J Neurol Sci; 1993 Oct 16; 119(1):43-52. PubMed ID: 8246010
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Elevated plasma levels of tissue inhibitors of metalloproteinase-1 and their overexpression in muscle in human and mouse muscular dystrophy.
    Sun G, Haginoya K, Chiba Y, Uematsu M, Hino-Fukuyo N, Tanaka S, Onuma A, Iinuma K, Tsuchiya S.
    J Neurol Sci; 2010 Oct 15; 297(1-2):19-28. PubMed ID: 20655547
    [Abstract] [Full Text] [Related]

  • 14. Abnormal localization of laminin subunits in muscular dystrophies.
    Hayashi YK, Engvall E, Arikawa-Hirasawa E, Goto K, Koga R, Nonaka I, Sugita H, Arahata K.
    J Neurol Sci; 1993 Oct 15; 119(1):53-64. PubMed ID: 8246011
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Preservation of the C-terminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy.
    Arahata K, Beggs AH, Honda H, Ito S, Ishiura S, Tsukahara T, Ishiguro T, Eguchi C, Orimo S, Arikawa E.
    J Neurol Sci; 1991 Feb 15; 101(2):148-56. PubMed ID: 2033400
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Analysis of dystrophin in muscular diseases by two-dimensional gel electrophoresis using agarose gels in the first dimension.
    Hamano K, Takeya T, Iwasaki N, Okoshi N, Fukubayashi T, Kirinoki M, Yao Y, Hirabayashi T, Takita H.
    Acta Neurol Belg; 1996 Jun 15; 96(2):102-7. PubMed ID: 8711982
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.